Fred Kurland
2019 - Aridis Pharmaceuticals
In 2019, Fred Kurland earned a total compensation of $323.2K as Chief Financial Officer at Aridis Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
Option Awards | $97,022 |
---|---|
Salary | $226,188 |
Total | $323,210 |
Kurland received $226.2K in salary, accounting for 70% of the total pay in 2019.
Kurland also received $97K in option awards.
Rankings
In 2019, Fred Kurland's compensation ranked 12,795th out of 13,971 executives tracked by ExecPay. In other words, Kurland earned more than 8.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 12,795 out of 13,971 | 8th |
Division Manufacturing | 5,181 out of 5,701 | 9th |
Major group Chemicals And Allied Products | 2,035 out of 2,200 | 8th |
Industry group Drugs | 1,752 out of 1,886 | 7th |
Industry Pharmaceutical Preparations | 1,297 out of 1,398 | 7th |
Source: SEC filing on April 16, 2020.
Kurland's colleagues
We found three more compensation records of executives who worked with Fred Kurland at Aridis Pharmaceuticals in 2019.